Cash flows from operating activities: | |
Net income (loss) attributable to Nabors | |
Adjustments to net income (loss): | |
Depreciation and amortization | 657.54M |
Depletion and other exploratory expenses | |
Deferred income tax expense (benefit) | -168.41M |
Deferred financing costs amortization | |
Pension liability amortization and adjustments | |
Discount amortization on long-term debt | |
Amortization of loss on hedges | |
Losses (gains) on long-lived assets, net | |
Losses (gains) on investments, net | |
Losses (gains) on debt retirement, net | |
Losses (gains) on derivative instruments | |
Share-based compensation | 24.07M |
Foreign currency transaction losses (gains), net | 5.92M |
Equity in (earnings) losses of unconsolidated affiliates, net of dividends | 221.92M |
Changes in operating assets and liabilities: | |
Accounts receivable | 255.46M |
Inventory | 14.66M |
Other current assets | 30.19M |
Other long-term assets | |
Trade accounts payable and accrued liabilities | -187.77M |
Income taxes payable | -22.5M |
Other long-term liabilities | |
Net cash provided by operating activities | 404.77M |
Cash flows from investing activities: | |
Purchases of investments | -24K |
Sales and maturities of investments | 643K |
Investment in unconsolidated affiliates | 0 |
Distribution of proceeds from asset sales from unconsolidated affiliates | |
Capital expenditures | -284.95M |
Proceeds from sales of assets and insurance claims | |
Net cash used for investing activities | -257.75M |
Cash flows from financing activities: | |
Increase (decrease) in cash overdrafts | 5K |
Proceeds from issuance of common shares | 562K |
Proceeds from revolving credit facilities | 560M |
Debt issuance costs | |
Reduction in long-term debt | -492.63M |
Repurchase of equity component of convertible debt | |
Settlement of call options and warrants, net | |
Purchase of restricted stock | |
Tax benefit related to share-based awards | |
Net cash used for financing activities | -223.37M |
Effect of exchange rate changes on cash and cash equivalents | -1.13M |
Net (decrease) increase in cash and cash equivalents | -77.49M |
Cash and cash equivalents, beginning of period | 254.53M |
Cash and cash equivalents, end of period | 177.04M |